Chaflty rtystfalltsn number 1178494 NORTHERN CANCER CARE & RESEARCH SOCIETY ANNUAL REPORT AND UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024 NORTHERN CANCER CARE & RESEARCH SOCIETY LEGAL AND ADMINISTRATIVE INFORMATION A knt#kmè XA G¢AJfr CW ATh3 t*NDG Rath#% Chatlty numbgr 1178491 Ptlficlp4 addr••• N(Nkn) Gyrae(l￿'ca1 Centro ￿lIabth Hogpilal GateS￿j TY￿ B Weal NE9 6SX Ftsrmwml Feirw(*l Rowl JOsn￿nd N8%%tasUe vpon Ty drKI W6 en9ianc NE21TJ B￿kE1$ HSBC 189 S(re (&)sfonh NI18EFi NORTHERN CANCER CARE & RESEARCH SOCIETY CONTENTS P8ge Trustees. rep￿t IrKlepwdeni exarrlnefs fÈPOrt atomori of lihawHI &fvilies Bakance Sheet Notes lo the firkwciBI Sla￿ments NORTHERN CANCER CARE & RESEARCH SOCIETY TRUSTEES. REPORT FOR THE YEAR ENDED 31 MARCH 2024 truyl¢¢s weseDt Ihai &nThJJl flywwl slalwiMMl¥ Ihe >ear ethj 31 Mwrth ?07.4. Tlv. fin3nci* statw.enls have b981 prppwd In With accwnlry oul In i lo Ihe nwcial 5taierrpnls and LX)iiikAy willi Ihe thanly s memorandijm tIMI C￿￿￿1..6& MLI 2C11 ard 'Ac¢￿JnIiIl￿ and Rotwy¢iry by Charil ¢5.. Staten￿l of Recom1￿(￿j dF4)knAib* lo thartses Ilithr ri(tounts in ctsrdaM wTrth Ihe FI￿anc￿l Ri.irtwliig sla￿Tj in the UK 8pd RawDllc of IreSaiic IFRS 1021" ￿eff￿1v* 1 JRnu8ry 20191. Objecll¥e¥ and a¢tlvltlés 'The Jts3fr-t5 of thè charity aro for Ih¢J Pi'JiTLAwi of resesfth nlo mèttgr5 rdalwiu Its the dwo*s and ..reaty￿￿ ol ¢ancor$ 11) **tsmtiri divj QOLLalw whelh8f (* memb￿$ ￿ Ifo ￿1c￿r￿lI dl)d nur￿nG PFDfesSL￿S or lif genwal puIAic sn ffloans o,. dLgJmsB treatrwil of tt1¥ ally￿a￿l. liiwloL&8 tta¥e paio Jjue rwd to isyJod Lry Il* Charty Cc•nffissKM in (kn•thng What Bckn¥ii*S Ihe (JLthly sWkJ lind￿r￿3￿. Achi￿*MentS and p•rformaneÈ Ckn l April d02J Ihe Ch￿tty r*eiwl a doDab'M Idalw £254,675 in rel8lKtft to Ihe ol a¥bgt% and 11a￿1￿j.eS [r￿n Ptth¢rr¢ CaTKgr Car& & Rv¥earch Srti nvnbe¢ 5143921. I￿l￿dI￿ tho abovo dLNldlv)ii.Ibo ."haniy 'ecewed I￿ne ￿taIn￿ £254.922 in Ihe 'fftaF l? 31 IAarth 2024 ¥TKJ '.4 ttXr￿rt1tU1e £32245. Thg Nofal surplus fu th9 year w&5 £222.677. Totsil free r8servgs br by the cthrity.* 31 Mwch 2024 at £222.67T. Thtt I rtsthe5 polty is to distribulo 118 Irwi* di¥J re3er¥es. sfv ￿ appropriate Mth the Tnjsfs cofittsluliuii, Thtr Iru3iee5 gNe sutvjrt to pers(x7s Ihtj fiokl ul Lwa{￿n canGer. Thertsrrfy Iw rk) rèslrkx￿￿ fL Trjg eni*¥y weraled trtxn (brHlK￿3 log￿￿s. strucliiiÉ*. 9ovornanee and manapment Tho thèniy its conirdlwl by 114 iJ)vt'.rning Jocumont. a tjeed d Inisl aryl r￿￿￿1¢5 & 00, The tttsstees who tho and up finArt￿ stateryw15 ￿re". A KiJ¢ukmt:t KAGodfvEy DI CVI Ang Di hr) G flfjlna¥elJ Thn tiu¥lees haye a duty t Kknlify risks IL¥ ￿.￿h IIE charty 15 ex￿￿1 ¢0 ensurè appropriate arè in i*asc*ut4e assuran￿ agwn* fiaud ￿ Qfryy. t￿lOeS. r4x*t was ¥wved by 8wd of TnKtees. Tru•ts• NORTHERN CANCER CARE & RESEARCH SOCIETY INDEPENDENT EXAMINER'S REPORT TO THE TRUSTEES OF NORTHERN CANCER CARE & RESEARCH SOCIEr Trp￿t to Ihe trustees on my exaDNna*on ot Ihe firionoal stale*￿*5 ol No￿1￿￿ CarThr Care & Reféarch kni ¢hHTrtyl y￿1r 6JThJ&* 31 IAwch 2024. fto$panslbilill•• and balis ol rtport Il* IlJSlees fjt thaty you are resrM)ns*l4 lor ￿ preparabm rftl* stafemeftl$ the r-qu￿em￿TrtS OF Iho Chèrtlit>$ knt 2011 (tho 2U11 kl) I report n ￿Spert ol my exarmarkn of Ihe chanly's stalements camed wt uTrJeT setXK>n 145 4)1 Ihe 2n, I AL'I In Airrying oul my I lia￿e l(slliJwoIJ all It*a apDltablo giw￿ by Ihe Lbdrils Loninii5s￿Th urfer se¢tson 14i15Xbl t)f the 2011 Art Independent e¥ttminerfs ststement Sin,.E) tThe ilidl Ily s y'i>¥i excee(led £25U.IIXI exanknner iiiembvr ot a toty listwJ in secbon 14< ol Ihc ?011 Aci I confrrm Ilai i anl auali.vl unoglake Ihe ex￿1￿￿31￿n l 8m a mortJOr ACCIl, whLn Is uiity uf Ihg Ibled I have COM￿￿1￿ my examnatson. I C(￿fIrM that no maitsr) ffly 311(*1￿ In c4)nneetK• wilh the OK8111tnaliun ljtv￿9 rn¢ lo that In ai)y Fr￿l￿nal rè%Jtsc¢ wcounilfg recordg wero not kéo In cl the tharity as re(wired by of the W11 Acl, or the flnai)cial SlalGtnoftls not wrd wih Iliose reu)Itls. ui tho irancial atst*n￿lIts do Dot r.[*71￿y wilh The a)￿￿atrIe f¢wm 4ntl Lrmtei)l or atttsunt$ Sei oul In ihe Cliari*e$ IAccouni$ and Rep(ylsi IteguL91ions 2CQ8 ￿hFJ[ thali any requir￿ment Ihat thè accoiJ#ls givo 3 and Is noi a rrk3ttoi consxknd as of an I no cwc¢m-. nnrf hgNv cumo tYms8 IN) ()tli()r rrwllers In conn￿l￿)n wth Iho cuiiiiniil¥)n lo wmlth allentson sl¥Ju￿ be drawn In mis ￿p(￿l in order io a WOPBr ￿¥je1s￿ndry ol the finarKaa' stalémÈnts to be reachL￿. 4oo- Nicholats G4Jnnltyiam l.'CCA Rcbson Lai(IlerJttnurtiants Lin¥1 -. iJmwoo(J Hutsse J&smoNJ N￿lO[ RecOfflnTr￿￿ PiklCtI¢ 10 thariues preparirrtj Ihe'.i accoiirily iii siLc(Yd3n¢e with the FwiarKial Rctp(>lirK Slandard a￿￿[able ￿ the tm( and RosiiibtrL & It5JlwKI iFR& 1021. iaffectits* l Jonu¥ry 2Q19). The th&¢ly is d P￿lI1 Bonofil Itiilly *FS defined ty FRS 102. charity IiÉl¥ ttikun advanlage cl woviwn5 ￿ the SORP try (hwts3s nol 10 prèpar8 • Si*oir4nt ol Gjsh flian￿lI Stat￿endS bow) de911￿￿ Irom iTha Cnant&g (A￿¢￿￿15 avj ReFxxisl Rwulawns 2008 Iv rffjuii&a lo rrfo¥￿e a Irue Th14 dFJPWtiJre Irwcfve.d f0knWir￿ thu SIKJ1viii￿l Recommend¢xl Pr'.IGIKE for charIt￿￿ &pp?lTrJ FRS 102 rather Ih4Tr the vi.rsioil 01 14e Slalem9nl ol Récommwdéxt Praclkè which * ¥ofe¢rt>J lo ¥1 Il* ReW*)ns I￿1 $nLZ been'will¥￿4wts. Th42 I￿a￿tAl stsithments are oroprirfrl in 51erlir9. IS Ihe lunc￿81 of Iho chodly. h1oiietary The firi.Ifii-.i%il ¥1111uTrienls have FYepar•J thjef i*sl I￿￿¥en￿n The Qfincp81 Mrxounting pokoes Wtèd are sel out t¥)￿V 1.2 Golng concofn AI of appr￿479 fiTran(>al slalerTXMItS. lh8 Injslees have a rvasofkth pxpp.I'.18'JOtI Ihat ts tharbty ha.8 wyoufLes ￿ conlinue itT opwaty)D81 gXLStlm Eor Ili*> loresee￿e lulure, Th￿ Iho trustr)oJ Iwe lo the c¢ncom basts 4Jl li*LY)uni¥wJ iii yewng th3 fir￿1r￿￿ 1.3 ChMrl¢able fvnd$ Unrv51ncl(..d ¢uri(ly are avadabk tsse al ol luth￿n￿ of rhHr141ble Hesliicled fu￿$ aro 6th4't3ct lo speL¥f￿ ccnditWlS by tS)rK)rs (X 9ranlurs as to ho* iiiay be uwj. Tr wrpJses Hnd use¥ ol I1￿ ljwth sg1 wl ￿leS k) tho rtnanuèl sta16mBrt5. 1A lrtomé LS feojgnisod ¥•*on the th•rty is kylly onlrt*d lo11 attoi ary perfonm8rtè ¢DrnJitKJnS havè >8en mal, Ihe eAn Ixi nLJsU￿d r¥abty, ayl rt i% Pfobablo Ihai it7corn wfjl L¥J recd¥ed. Cash donal•￿8 recogni*J ￿ rgrevl. Cknr donal(*)s ¢yv the tlonly has I￿17 40lifi*d vl thrwtK)n, Lnks& perfrne LCndi.'MY￿ reqJire delerral ol Ihe amfxjnl lrncomè lax in r￿￿1￿ Its thswlK)ns reielvL¥J unthr Gtft Avj or dEeds ol cow4nl Is rwwiils•Y al Ine of Ihp gknatvji. NORTHERN CANCER CARE & RESEARCH SOCIETY NOTES TO THE FINANCIAL STATEMENTS ICONTINUEDI FOR THE YEAR ENDED 31 MARCH 2024 Acetsim¢lng poRttS9s Icontlnuodl 1.5 E)tp¢nthtu Exwrdilure B reCWNs￿j &iGe Ihefe Is a l* or cur6Eructsve obhjalw fvi Ir¥mslor bonefil to a third Pdrty. Il * pr￿)0￿￿ a trarisler ol e￿￿nIG b￿ell￿ wil b& ITI *1ileft*>r￿ yntl th8 atrx)uTht ul the obligalofi can be meas*Jred ￿￿)￿.Y. Exynthttsfp Is d2ssif*d by ac11*71y The of Ktmty made up of tolai ol direct ￿51& shargd a)sls Including ￿1¥￿￿7 thsis Invd¥ai In u￿rt￿Ing eath athily D¥e(a u5ts 8tliibulablo to a single activity a", p *lncaled ¢Jifeclty lo Ihal activity. Slwo4 cosls %thich G￿tr￿1& 10 rnOfQ I￿all •nè aelivily &irl suprKKt ¢0S1s wfKh noi attrttbulaD￿ 10 a sir,gltr ure atvwtLwd lyil*oèn ttK)?e vilEs on a bass ¢.nn41$1p.ni thrth Ihe uso ol ros￿Irn￿s. Centrd staff ￿51S are alby.aied f*b Ihe bags ol lim* (lep(e0a￿Qnch¥9es are aknted cn the ot thc a$50(3 w. 1.6 Ca8h and equhfalents Ldsh &i¥*i o(iiiiYokJnis ￿s￿ nand. dowsils Tr￿k1 al call wilti yhorl-lerm I￿￿[1 inveslmenis ￿lIh (xynaF m3twrt￿S ol threÈ bank ovétdrDfts. B•)k overorafts ate shJwn withln l)orriYthnqs In wrs)nr ILqtsM*s. I￿O￿e Irall donations and leg￿leS Unrestrlcted Unrestrieted fufid• lui)ds 2024 2023 Oonalims aThJ gift5 254.892 Oonaliffie5 I￿.bud0¥ f 254.875 tron8trred fmm ￿￿ern Cancof Car& & Fle&o*Lh SLK'i￿Y l April 202 Expond61ui• oil charli4bl• tteti¥ltlè• Researeh Cancor 2024 Direcl costs G¢8rrt fuThJiry cf ac*.￿110￿ notg 41 29.743 ar• of support and gov•rn¥+c• {Mg not• 51 &Jpport Go¥ern8n(* 1.362 1.140 32,245 AnAly*l# by fvnd Unreslitted tw¥ts 32245 NORTHERN CANCER CARE & RESEARCH SOCIETY NOTES TO THE FINANCIAL STATEMENTS {CONTINUED) FOR THE YEAR ENDEO 31 MARCH 2024 poy•bl• Ro8oar¢h Cancer 2024 2023 nts to W￿￿1vI￿. Ne*raJ+ urnvo￿ly Ifj 947 GThrrt5 to i￿￿(lU*S 12.7 29.743 Swpport costs allo¢atgd lo a¢iivitl•• R•6•arch Cbncer 2024 23 Othei expendituf Bank Goveinan 1.298 1.14Q 2024 2023 ACc￿Lin￿nCY .14 1 140 Trnstees Ntne ol the tnmtoes {tr 8ny Wmecled vnth Iheml ro(*¥ed renKwalK)n tr t￿nts1t$ tr￿1 Iho challty d￿lD9 ye¥. TaxoU¢)n Th¢ cttarty eiE¥npt frtyn lax￿￿ because al its • 4Wed torchw￿JIe purposes Cfe(litrys'. arnountg talliry *ith•n one y 2024 2023 r&ds and doFwod ino 2,280 NORTHERN CANCER CARE & RESEARCH SOCIETY NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2024 Unrèktrlcted lunds iJrw¢slw.lod funds of tho crorrty c(xnptse the unexpOnd￿l of dMalth)ns ard 5fanls a Dol sub￿1 10 Spear￿ cuKhlKJr6 by find gionlors 3$ ￿ how ltsy rray Thps¢ dat￿￿010(1 fuT'ds s*h*,h have b&en 5fj1 a5wJe out of unr95tricted IwKL4 Jy mo trusle&s for spocifr witx)ses. A11 Aprll 2023 IncoMSn9 rvdources Rgsources At 31 Mlircli xpeiided 2024 GvY4.'al ILJnds 254.922 132,2451 222,677 10 Rblalod party tr￿S0￿￿on5 There no (*k)satAè ￿[*.￿ pawty dyr1ng yEw12023. ml.